Exogenous and Endogenous Glucocorticoids in Rheumatic Diseases

被引:70
|
作者
Buttgereit, Frank [1 ,2 ]
Burmester, Gerd-Ruediger
Straub, Rainer H. [3 ]
Seibel, Markus J. [4 ,5 ]
Zhou, Hong [4 ]
机构
[1] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany
[2] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-10117 Berlin, Germany
[3] Univ Hosp, Regensburg, Germany
[4] Univ Sydney, Sydney, NSW 2006, Australia
[5] Concord Repatriat Gen Hosp, ANZAC Res Inst, Sydney, NSW, Australia
来源
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 01期
基金
英国医学研究理事会;
关键词
RAT ALVEOLAR MACROPHAGES; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; CIRCADIAN-RHYTHMS; MORNING STIFFNESS; INDUCED ARTHRITIS; RECEPTOR AGONIST; INTERLEUKIN-6; OSTEOBLASTS; RELEASE; STRESS;
D O I
10.1002/art.30070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [21] Glucocorticoids in the treatment of rheumatic diseases - An update on the mechanisms of action
    Buttgereit, F
    Straub, RH
    Wehling, M
    Burmester, GR
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3408 - 3417
  • [22] The safety of low-dose glucocorticoids in rheumatic diseases
    Hwang, Y. G.
    Saag, K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : S104 - S112
  • [23] Glucocorticoids in Patients with Rheumatic Diseases: Friends or Enemies of Bone?
    Ciccarelli, Fedra
    De Martinis, Massimo
    Ginaldi, Lia
    [J]. CURRENT MEDICINAL CHEMISTRY, 2015, 22 (05) : 596 - 603
  • [24] GLUCOCORTICOIDS IN RHEUMATIC DISEASES: WHAT DO WE KNOW?
    Nesterenko, V. A.
    Karateev, A. E.
    Makarov, M. A.
    Bialik, E. I.
    Makarov, S. A.
    Arkhipov, S. V.
    Bialik, V. E.
    Roskidailo, A. A.
    Naryshkin, E. A.
    Khramov, A. E.
    Dubinin, A. O.
    Maglevanny, S. V.
    Filatova, E. S.
    Polishchuk, E. Y.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S212 - S213
  • [25] Low-dose glucocorticoids in rheumatic diseases: Introduction
    Pincus, T.
    Bijlsma, J. W. J.
    Braun, J.
    Buttgereit, F.
    Cutolo, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : S2 - S4
  • [26] The Art and Science of Tapering Glucocorticoids in Patients with Rheumatic Diseases
    Mofrad, Alireza
    Rajbhandary, Rosy
    Panush, Richard S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1252 - 1252
  • [27] Impact of glucocorticoids on appearance and sense of self in rheumatic diseases
    Lax, Stephanie J.
    Dures, Emma
    Bridgewater, Susan
    Silverthorne, Christine
    Lowndes, Vivien
    Richards, Pamela
    Dawson, Jill
    Hill, Catherine
    Goodman, Susan
    Mackie, Sarah L.
    Ndosi, Mwidimi E.
    Pearce, Fiona A.
    Robson, Joanna
    [J]. RHEUMATOLOGY, 2024, 63
  • [28] Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
    Korczowska-Lacka, Izabela
    Slowikowski, Bartosz
    Piekut, Thomas
    Hurla, Mikolaj
    Banaszek, Natalia
    Szymanowicz, Oliwia
    Jagodzinski, Pawel P.
    Kozubski, Wojciech
    Permoda-Pachuta, Agnieszka
    Dorszewska, Jolanta
    [J]. ANTIOXIDANTS, 2023, 12 (10)
  • [29] IDENTIFICATION OF ENDOGENOUS AND EXOGENOUS GLUCOCORTICOIDS BY HPLC-MS IN HUMAN URINE
    Dikunets, M. A.
    Appolonova, S. A.
    Rodchenkov, G. M.
    [J]. PHARMACEUTICAL CHEMISTRY JOURNAL, 2010, 44 (06) : 328 - 333
  • [30] Identification of endogenous and exogenous glucocorticoids by HPLC-MS in human urine
    M. A. Dikunets
    S. A. Appolonova
    G. M. Rodchenkov
    [J]. Pharmaceutical Chemistry Journal, 2010, 44 : 328 - 333